Urothelium Tissue Engineering Using Biopsies From Transurethral Resection of Prostate

Launched by CENTRAL HOSPITAL, NANCY, FRANCE · Oct 4, 2018

Keywords

ClinConnect Summary

This clinical trial is exploring a new approach to help patients with certain bladder conditions, such as spina bifida and bladder exstrophy. The researchers want to see if they can create a new type of bladder tissue using cells taken from a procedure called Trans-Urethral Resection of Prostate (TURP). This method may help patients who need bladder augmentation or replacement, providing a more natural solution without some of the side effects seen in previous treatments.

To be eligible for the trial, you must be a male patient who needs a TURP procedure and have a prostate weighing at least 30 grams. You also need to be of legal age and agree to participate in the study. If you choose to join, you can expect to contribute to important research that could lead to better treatments for bladder issues in the future. It's important to note that this study is not yet recruiting participants, so there will be some time before it begins.

Gender

MALE

Eligibility criteria

• Inclusion Criteria:
• • Patient needing a Transurethral Resection of Prostate (TURP)
• • Weight of prostate (evaluated by ultrasonography)greater than or equal to 30 grams
• • Affiliation to a social security system
• • Patient over the age of majority
• • Patient receiving complete information on research organization without opposition to the use of biological specimen
• Exclusion Criteria:
• • Patient for whom no TURP is realized during endoscopic procedure
• • Patient for whom no resection is realized on the bladder neck
• • Patient with prostate weight estimated under 30 grams
• • Patient who opposed to the realization of the study